BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27884041)

  • 1. Follow-up strategies for patients treated for non-metastatic colorectal cancer.
    Jeffery M; Hickey BE; Hider PN; See AM
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002200. PubMed ID: 27884041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up strategies for patients treated for non-metastatic colorectal cancer.
    Jeffery M; Hickey BE; Hider PN
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002200. PubMed ID: 31483854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up strategies for patients treated for non-metastatic colorectal cancer.
    Jeffery M; Hickey BE; Hider PN
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002200. PubMed ID: 17253476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up strategies for patients treated for non-metastatic colorectal cancer.
    Jeffery GM; Hickey BE; Hider P
    Cochrane Database Syst Rev; 2002; (1):CD002200. PubMed ID: 11869629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.
    Høeg BL; Bidstrup PE; Karlsen RV; Friberg AS; Albieri V; Dalton SO; Saltbæk L; Andersen KK; Horsboel TA; Johansen C
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31750936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
    Chan DLH; Segelov E; Wong RS; Smith A; Herbertson RA; Li BT; Tebbutt N; Price T; Pavlakis N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007047. PubMed ID: 28654140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial breast irradiation for early breast cancer.
    Hickey BE; Lehman M; Francis DP; See AM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007077. PubMed ID: 27425375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up strategies for women treated for early breast cancer.
    Moschetti I; Cinquini M; Lambertini M; Levaggi A; Liberati A
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD001768. PubMed ID: 27230946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Yuan Y; Wan X; Yin D; Li R; Chen W; Suo C; Song H
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD011300. PubMed ID: 34870327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
    Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.
    Chan KK; Glenny AM; Weldon JC; Furness S; Worthington HV; Wakeford H
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010341. PubMed ID: 26625332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesh versus non-mesh for inguinal and femoral hernia repair.
    Lockhart K; Dunn D; Teo S; Ng JY; Dhillon M; Teo E; van Driel ML
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011517. PubMed ID: 30209805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.
    Bulsara VM; Worthington HV; Glenny AM; Clarkson JE; Conway DI; Macluskey M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006205. PubMed ID: 30582609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-containing regimens for metastatic breast cancer.
    Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.